New heart monitor device tested in small study

NCT ID NCT07224906

Recruiting now Knowledge-focused Sponsor: HemoCept Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new device called HemoCept during a standard heart procedure called right heart catheterization. The goal is to see if the device can accurately measure pressure in the heart's blood vessels. About 50 adults with conditions like pulmonary hypertension or heart failure will take part. The study is observational, meaning it only collects data and does not provide any treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HemoCept device
What this could lead to: If successful, this could lead to a less invasive way to measure heart pressure during catheterization.
What could go wrong: This is a small, early pilot study with only 50 participants. It is observational, so it does not test treatment or prove the device works better than current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGESTIVE HEART FAILURE(CHF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure heart failure heart valve disorder pulmonary hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONGESTIVE HEART FAILURE(CHF) PULMONARY HYPERTENSION VALVE DISEASE, HEART

Contacts and locations

Locations

Boulder Heart
RECRUITING

Boulder, Colorado, 80303, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.